This compound is a quinoline derivative characterized by a cyclopropyl group and a fluorophenyl substituent. It is primarily used as an active pharmaceutical ingredient in the manufacturing of pharmaceutical products.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 121659-86-7
Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
pharmaceutical intermediate
4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide-d5
active pharmaceutical ingredient impurity standard
Naratriptan
active pharmaceutical ingredient for migraine
Anastrozole Dimer Impurity
impurity reference standard
4,4,5,5-tetradeuterio-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
Deuterated standard for furazolidone analysis
(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol
n.a
3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline
pharmaceutical intermediate
(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile
Pharmaceutical intermediate
methyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
RNXQZVFWKIPEOJ-UHFFFAOYSA-N
COC(=O)C1=C(C2=CC=CC=C2N=C1C3CC3)C4=CC=C(C=C4)F
—